OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 10, 2020
Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta; GlaxoSmithKline) is indicated for the treatment of asthma in patients aged 18 years and older.
September 09, 2020
Tramadol hydrochloride (Qdolo; Athena Bioscience) oral solution is indicated for use when pain is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
September 03, 2020
Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.
August 28, 2020
Here's the coronavirus-related news from this week that you should know.
August 27, 2020
Abbott’s BinaxNOW COVID-19 Ag Card rapid test produces results in 15 minutes.
August 25, 2020
Amisuplride injection (Barhemsys; Acacia) is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class.
August 20, 2020
Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.
August 07, 2020
Risdiplam (Evrysdi; Genentech) is the only SMA therapy that can be administered at home.
August 06, 2020
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
August 05, 2020
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive disorder.
July 15, 2020
The therapy will also be available for individuals with asthma and suspected COVID-19 infection.
July 10, 2020
The new app feature will also soon function with smart labels, which can be scanned and read aloud.
July 06, 2020
Xeris Pharmaceuticals’ new glucagon injection (Gvoke HypoPen), a ready-to-use glucagon formulation in a premixed autoinjector, is now available by prescription.
The FDA has granted emergency use authorization to an additional combination diagnostic test for influenza and COVID-19.
July 03, 2020
Fostemsavir (Rukobia, ViiV Healthcare) is indicated for use in heavily treatment-experienced adults with multidrug resistant HIV-1 infection.
July 01, 2020
The fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase (Phesgo; Genentech) can be administered subcutaneously for patients with HER2-positive breast cancer.
June 29, 2020
A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.
June 26, 2020
Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
June 23, 2020
The first and only one of its kind, metoclopramide nasal spray offers relief to often debilitating symptoms of the gastrointestinal disease.
June 22, 2020
On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.